Moderna is working with US government scientists to study an experimental booster shot that targets a concerning new variant of the coronavirus and has raised its global COVID-19 vaccine production goal for this year by 100 million doses. The US biotech company says it has produced raw material for a booster shot aimed at addressing the virus variant first found in South Africa that may be more resistant to existing vaccines. It has shipped the vaccine to the United States' National Institutes of Health for additional study. Moderna is experimenting with several potential ways to combat new variants of the virus. They include an additional booster shot that targets the variant now prevalent in South Africa and spreading globally, a combined booster shot that mixes its current COVID-19 vaccine with the experimental shot, and an extra booster shot on top of its current two-dose vaccine. Several studies suggest the South African variant is more resistant to existing vaccines than other variants of the coronavirus. Moderna also raised its expected vaccine production for 2021 to 700 million doses globally from 600 million and is exploring manufacturing improvements that could raise production this year to as much as one billion doses. Australian Associated Press
Moderna has raised its expected vaccine production for 2021 to 700 million doses from 600 million.
Moderna is working with US government scientists to study an experimental booster shot that targets a concerning new variant of the coronavirus and has raised its global COVID-19 vaccine production goal for this year by 100 million doses.
The US biotech company says it has produced raw material for a booster shot aimed at addressing the virus variant first found in South Africa that may be more resistant to existing vaccines.
It has shipped the vaccine to the United States' National Institutes of Health for additional study.
Moderna is experimenting with several potential ways to combat new variants of the virus.
They include an additional booster shot that targets the variant now prevalent in South Africa and spreading globally, a combined booster shot that mixes its current COVID-19 vaccine with the experimental shot, and an extra booster shot on top of its current two-dose vaccine.
Several studies suggest the South African variant is more resistant to existing vaccines than other variants of the coronavirus.
Moderna also raised its expected vaccine production for 2021 to 700 million doses globally from 600 million and is exploring manufacturing improvements that could raise production this year to as much as one billion doses.
Australian Associated Press
Follow us
Ad blocker issue
Your ad blocker may be preventing you from
being able to log in or subscribe.
